Rare diseases
Investigational molecules
Locations
Back to Poland1 013 clinical trials in Lodz, Poland across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy
PolandStudy of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
PolandStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
PolandStudy on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis
PolandStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
PolandPolandStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
PolandStudy on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
PolandStudy on Masupirdine for Treating Agitation in Alzheimer's Dementia Patients
PolandStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
PolandStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on respiratory viral infections and preventive vaccines, particularly targeting RSV and influenza in older adults. Studies evaluate vaccine efficacy and immune responses to protect against severe respiratory diseases.
Multiple studies assess combination vaccines and co-administration strategies to enhance protection against multiple respiratory pathogens.
Innovative research examining treatments for plaque psoriasis and related conditions. Trials investigate novel therapeutic approaches including oral medications and biological treatments for moderate to severe cases.
Studies focus on measuring improvement in disease severity and quality of life outcomes for patients.
Comprehensive research on meningococcal and pneumococcal vaccines, with special attention to pediatric populations. Studies evaluate safety profiles and immune responses across different age groups.
Trials incorporate multiple age cohorts from infants to adolescents, ensuring comprehensive vaccine effectiveness data.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
